![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Schering-Plough to Close San Diego Research Site
Schering-Plough to Close San Diego Research Site
May 5, 2005
Schering-Plough announced the closing of its La Jolla-based research site, Canji, and the creation of a new unit. Schering-Plough Biopharma will be formed through the integration of Canji, which develops therapeutics based on tumor suppressor genes, and its other West Coast facility, DNAX Research Institute. The idea is to bring together two companies with leading scientific expertise under one roof, said Rosemarie Yancosek, media spokesperson for Schering-Plough.
Yahoo News (http://news.yahoo.com/news?tmpl=story&u=/sddt/20050503/lo_sddt/scheringploughtoclosesandiegoresearchsite)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct